The Federal Trade Commission launched its lawsuit against Hims & Hers on July 29, 2026, accusing the provider of sharing private medical condition data with third-party advertising platforms. This move directly contradicts the company’s public claims regarding consumer privacy protections. The investigation led by the Los Angeles-based firm now seeks to determine the extent of potential securities law violations resulting from these undisclosed practices.
In section Releases
Hims & Hers Health Faces Shareholder Investigation Following FTC Lawsuit
Shareholders of Hims & Hers Health are under scrutiny by litigation firm Schall, Brown & Schwartz following federal allegations that the company mishandled sensitive consumer data. The investigation centers on whether the firm misled investors by failing to disclose deceptive privacy, billing, and cancellation practices prior to a recent FTC legal action.
Investors who incurred losses linked to these disclosures are being encouraged to reach out to partners Brian Schall or David Schwartz. The firm, which specializes in national shareholder rights litigation, is evaluating whether the company’s communications to the market constituted false or misleading statements. Those seeking to discuss their legal standing may contact the firm’s Century Park East office or visit their website to participate in the ongoing review.
Comments (0)
No comments yet. Be the first!